Document Detail


Do antipsychotics limit disability in schizophrenia? A naturalistic comparative study in the community.
MedLine Citation:
PMID:  20174516     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
BACKGROUND: Though antipsychotics are effective against symptoms of schizophrenia and prevent relapses, their effect on disability has not been studied in a comparative design.
AIM: To compare disability of schizophrenia patients receiving continuous antipsychotic treatment with that of those not receiving or receiving irregular treatment in a rural community setting using a naturalistic comparative study design.
PATIENTS AND METHODS: Disability was assessed in 182 schizophrenia patients living in Thirthahalli Taluk of Shimoga District, Karnataka, using Indian Disability Evaluation and Assessment Scale (IDEAS). Fifty patients (27.5%) were receiving regular treatment in the previous 2 years and their disability was assessed for the period when they were on antipsychotics. The remaining 132 patients (72.5%) had off-antipsychotics periods in the previous 2 years and their disability was assessed for the period when they were off-antipsychotics.
RESULTS: Patients on antipsychotics had significantly less disability across all domains of disability and in total IDEAS scores. Multivariate regression analysis showed that treatment status predicted disability scores after controlling for the effects of the confounding factors. Different levels of exposure to antipsychotic treatment were associated with different levels of disability.
CONCLUSIONS: Treatment with antipsychotics is associated with significantly less disability. There is an urgent need to bring schizophrenia patients under the umbrella of treatment.
Authors:
Jagadisha Thirthalli; Basappa K Venkatesh; Magadi N Naveen; Ganesan Venkatasubramanian; Udupi Arunachala; Kengeri V Kishore Kumar; Bangalore N Gangadhar
Related Documents :
20686456 - Relapse prevention in schizophrenia and schizoaffective disorder with risperidone long-...
2859366 - A corticosteroid/dopamine hypothesis for psychotic depression and related states.
15863796 - Evidence for onset of antipsychotic effects within the first 24 hours of treatment.
18632256 - Attribution style as a factor in psychosis and symptom resolution.
21654506 - Effects of creatine supplementation in rett syndrome: a randomized, placebo-controlled ...
21171936 - Herbal treatments for alleviating premenstrual symptoms: a systematic review.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Indian journal of psychiatry     Volume:  52     ISSN:  1998-3794     ISO Abbreviation:  Indian J Psychiatry     Publication Date:  2010 Jan 
Date Detail:
Created Date:  2010-02-22     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0013255     Medline TA:  Indian J Psychiatry     Country:  India    
Other Details:
Languages:  eng     Pagination:  37-41     Citation Subset:  -    
Affiliation:
Department of Psychiatry, National Institute of Mental Health And Neurosciences (NIMHANS), Bangalore, India.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Neuroanatomical correlates of psychopathology in antipsychotic-naïve schizophrenia.
Next Document:  The influence of negative mood on heart rate complexity measures and baroreflex sensitivity in healt...